CYPB - Cypress BioScience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPB - Cypress BioScience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Amigo Mike who wrote (34)	1/13/1998 10:48:00 PM
From: Sergio H	Read Replies (2) of 586

Mike, besides Allen and Co., Aries Trust bought almost 1.4 million shares in Oct. Not familiar with Aries but Allen is the number one shareholder and Aries is number two. One analyst following the co. is Cruttenden and Co. They have a buy rating that should be upgraded to a strong buy when CYPB announces their marketing plan, IMO. Gilmore Securities was providing coverage and is not at this time. It would not be suprising to see them come back into the picture as well as some other analysts. Yesterday's volume of 1,260,900 shares was slighlty exceeded by today's volume of 1,291,400. The buying came late in today's session and there is no reason not to expect to see a new 52 week high this week. Rheumatoid arthritis is a potentially crippling autoimmune disease that is estimated to affect over 5,000,000 people in North America and Europe. The company's potential is huge. Sergio

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next